Pharmacology, Toxicology and Pharmaceutical Science
Nasopharynx Carcinoma
89%
Malignant Neoplasm
64%
Disease
63%
Vitamin D
62%
Infection
49%
Breast Cancer
49%
Cross-Sectional Study
45%
Chemotherapy
45%
Tumor Necrosis Factor
44%
Nasopharynx Cancer
37%
Cohort Study
36%
Chemoradiation Therapy
36%
Cisplatin
31%
Hypothyroidism
31%
Hypovitaminosis D
31%
Vitamin D Deficiency
31%
Nimotuzumab
31%
Myelodysplastic Syndrome
31%
Coronavirinae
31%
Anterior Ischemic Optic Neuropathy
31%
Colecalciferol 24 Hydroxylase
31%
Anticoagulant Agent
31%
Progression Free Survival
26%
Overall Survival
25%
SARS Coronavirus
24%
Tree
23%
Non Insulin Dependent Diabetes Mellitus
20%
Antiplatelet
19%
Adverse Event
18%
Dengue
18%
Comorbidity
18%
Acute Kidney Failure
17%
Inflammation
17%
Epidermal Growth Factor Receptor
17%
Head and Neck Cancer
16%
Thrombosis
16%
Cardiovascular Disease
16%
COVID-19 Vaccine
15%
Trastuzumab Emtansine
15%
Morbidity
15%
Caspase 3
15%
P-Selectin
15%
Mannitol
15%
Kidney Disease
15%
Hydration
15%
Primary Tumor
15%
mRNA Vaccine
15%
Vaccine
15%
CD40 Ligand
15%
Deep Vein Thrombosis
15%
Keyphrases
Cancer Patients
100%
Indonesia
61%
Nasopharyngeal Carcinoma
37%
Jakarta
37%
Serum 25(OH)D Levels
36%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
35%
S-RBD IgG
33%
Vitamin D Deficiency
31%
Umbilical Cord
31%
Hospitalized COVID-19 Patients
31%
Clinical Outcomes
31%
Vitamin D Status
31%
Platelet-rich Plasma
31%
Acute Kidney Injury
31%
Coronavirus Disease 2019 Vaccine
31%
Myelodysplastic Syndrome
31%
Aldehyde Dehydrogenase 2 (ALDH2)
24%
Neutralizing Antibodies
24%
Hypothyroidism
23%
Anti-SARS-CoV-2
23%
Breast Cancer Stem Cells
22%
Severe COVID-19
20%
COVID-19 Cases
20%
Referral Hospital
20%
Secretome
20%
Radiotherapy
19%
Progression-free Survival
19%
Post-irradiation
19%
Bone Marrow Mononuclear Cells
18%
Recurrent Nasopharyngeal Carcinoma
17%
Multicenter Cross-sectional Study
17%
Survival Tree
15%
Safety Trial
15%
Trastuzumab Emtansine
15%
T-DM1
15%
Hypothyroid
15%
Concurrent Chemoradiation
15%
Metastatic Status
15%
Thrombosis Risk
15%
Platelet-to-white Blood Cell Ratio
15%
Heme oxygenase-1 (HO-1)
15%
Low-dose Cisplatin
15%
Spike Receptor Binding Domain
15%
Cisplatin-based Chemotherapy
15%
Patient Delay
15%
Anti-SARS-CoV-2 Neutralizing Antibody
15%
Anti-inflammatory Mediators
15%
Antibody Protein
15%
Macrophage Culture
15%
Level Function
15%
Medicine and Dentistry
Breast Cancer
49%
Platelet
47%
Cross Sectional Study
35%
Cancer Stem Cell
31%
Umbilical Cord
31%
COVID-19
31%
Arteritic Anterior Ischemic Optic Neuropathy
31%
Nasopharynx Carcinoma
31%
Malignant Neoplasm
27%
Progression Free Survival
23%
Antiplatelet
20%
Apoplexy
19%
Optical Coherence Tomography Angiography
19%
Metastatic Carcinoma
17%
ALDH1A1
17%
Overall Survival
17%
Thrombosis
16%
Trastuzumab Emtansine
15%
Patient Referral
15%
Muscle Injury
15%
Stem Cell
15%
Therapy Delay
15%
Head and Neck Cancer
15%
Adipose Tissue
15%
Syndrome of Inappropriate Antidiuretic Hormone Secretion
15%
Immunosuppressive Drug
15%
Systemic Lupus Erythematosus
15%
Adverse Event
15%
Coronary Artery Disease
15%
Esophageal Varices
15%
PADGEM Protein
15%
Giant Condyloma Acuminatum
15%
Cohort Analysis
15%
Calcium Ion
15%
Deep Vein Thrombosis
15%
Immune Cell Infiltration
15%
Liver Cirrhosis
15%
Steroid Therapy
15%
Epidermal Growth Factor Receptor 2
15%
Gamma Urogastrone
15%
Levator Ani Muscle
15%
Hepatitis B Virus
15%
Thrombocytopenia
15%
Coronary Artery
15%
Hemoperitoneum
15%
Randomized Controlled Trial
15%
Artery Lesion
15%
Female Genital Tract Cancer
15%
Thrombocyte Rich Plasma
15%
Hemispheric Dominance
15%
